Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial
- 7 May 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (4), 2000663
- https://doi.org/10.1183/13993003.00663-2020
Abstract
No abstract availableFunding Information
- Bundesministerium für Bildung und Forschung (BMBF 01EO1003 and 01EO1503)
This publication has 16 references indexed in Scilit:
- Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolismResearch and Practice in Thrombosis and Haemostasis, 2017
- External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolismThrombosis and Haemostasis, 2017
- Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro–Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxabanThrombosis and Haemostasis, 2016
- European Union-28: An annualised cost-of-illness model for venous thromboembolismThrombosis and Haemostasis, 2016
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsBlood, 2014
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThrombosis Journal, 2013
- Outpatient treatment in patients with acute pulmonary embolism: the Hestia StudyJournal of Thrombosis and Haemostasis, 2011
- Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trialThe Lancet, 2011
- Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE RegistryThrombosis and Haemostasis, 2008